Clinical trials
Active, not recruiting Phase 1 Lymphoma, T-Cell, Cutaneous trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Bio-Path Holdings, Inc. | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Treeline Biosciences, Inc. | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Cutaneous | 6 |
| Lymphoma | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, T-Cell, Peripheral | 3 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Lymphoma, T-Cell | 2 |
| Mycosis Fungoides | 2 |
| Hodgkin Disease | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.